Newsletter Subject

Critical Levels of Support in Biotech Stocks

From

ragingbull.com

Email Address

support@ragingbull.com

Sent On

Thu, Aug 12, 2021 06:44 PM

Email Preheader Text

Hello Trader, Yesterday the overall market, SPDR S&P 500 ETF , was up 0.25% on the day, while the He

[BiotechBreakouts] Hello Trader, Yesterday the overall market, SPDR S&P 500 ETF (SPY), was up 0.25% on the day, while the Health Care Select Sector SPDR Fund (XLV) was down 0.99%. The IBB ETF was down 2.99%. Health care and biotech stocks were the weakest industries yesterday, led lower, predominantly, by a few stocks. MRNA continued its pullback, coming off a further 15.64% and now 22.55% off the 52w high. BNTX was down 13.76% yesterday and off 22.59% from its 52w high. PFE pulled back 3.9% yesterday and now finds itself down 4.65% from the high it put in two days ago. [image] In the above map, from [Finviz,]( it is clear that while the overall market was mainly green, stocks in the healthcare and drug manufacturers sector were relatively weak. [image] With this bubble chart from [Finviz,]( it is more apparent that most large-cap health care stocks were negative on the day. Weakness in large-cap healthcare stocks like PFE, LLY, DXCM, PRGO, ANTM, and UNH dragged the entire sector lower. MRNA was by far the weakest S&P 500 healthcare stock, for the second day in a row, with the stock being down 15.64%. With the relative weakness in popular healthcare stocks, I want to go over crucial support levels in a few names to prepare for a possible bounce trade. [Click here to continue…]( Biotech Breakouts Research Team P.S. For a limited time, we’ve slashed the price of the Biotech Breakouts considerably—[for the first 50 traders who act.]( P.P.S. [Supply is limited—don’t miss this opportunity!]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. RESULTS PRESENTED NOT TYPICAL OR VERIFIED.RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial.However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [Ragingbull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, [Ragingbull.com](, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. If you have a current active subscription with Biotech Breakouts you will need to contact us [here]( if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com. [Unsubscribe]( RagingBull.com, LLC 62 Calef Hwy #233 Lee, New Hampshire 03861 United States (833) 265-1271

Marketing emails from ragingbull.com

View More
Sent On

06/06/2024

Sent On

04/06/2024

Sent On

03/06/2024

Sent On

02/06/2024

Sent On

31/05/2024

Sent On

28/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.